Q2 2026 Healthpeak Properties, Inc Earnings Call Transcript
Key Points
- Healthpeak Properties Inc (DOC) reported strong outpatient medical leasing with 5% cash re-leasing spreads and modest tenant improvements, outperforming pre-merger averages.
- The company successfully completed a $1 billion Brookfield joint venture, strengthening its balance sheet and providing alternative equity capital for growth.
- Life science portfolio showed significant improvement, with total occupancy up 140 basis points since year-end 2025 and strong leasing momentum in key markets like Torrey Pines.
- Senior housing portfolio is on track to double in size this year, with $1.8 billion in acquisitions closed and strong NOI growth of 19%.
- The company raised its FFO guidance by $0.02 per share, driven by improved same-store NOI expectations across lab and senior housing segments.
- Life science same-store NOI is still negative, and the company cannot predict when it will inflect positively, indicating ongoing sector challenges.
- Boston lab market remains challenged due to supply overhang, which could pressure leasing and pricing in that region.
- Outpatient medical cash re-leasing spreads decelerated slightly in Q2, partly due to a competitive lease renewal in Boston.
- Elevated borrowing costs are prompting the company to manage debt maturities carefully, limiting near-term capital deployment flexibility.
- The company's stock buyback activity is limited, as current prices are not sufficiently below intrinsic value, reducing shareholder return options.
Good morning, and welcome to the Healthpeak Properties, Inc. second quarter 2026 conference call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Andrew Johns, Senior Vice President, Investor Relations. Please go ahead.
Welcome. Today's conference call contains certain forward-looking statements. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, these statements are subject to risks and uncertainties that may cause actual results to differ materially from our expectations. A discussion of risk and risk factors is included in our press release and detailed in our filings with the SEC. We do not undertake a duty to update any forward-looking statements. Certain non-GAAP measures will be discussed on this call. In an 8-K that we filed with SEC yesterday, we have reconciled all non-GAAP financial measures to the most directly comparable
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
